FDA removes black box warning on hormone products

By now most of you are probably aware that last Monday, the FDA made a rather large announcement removing the black box warning from the labels of menopausal hormone therapy products, both local low-dose vaginal estrogen as well as systemic hormones. This was instituted in 2003 shortly after the Women’s Health Initiative news broke. This is a welcomed action. For the last twenty-three years, there has been stigma and fear, not only among patients who may have been excellent candidates for horm...